Find the BEST weed in...
Senate Spending Bills Would Keep DC Cannabis Sales Blocked
Nov 19, 2026
Source:
Tom Angell
Marijuana Moment
A key Senate committee has released its latest spending bills along with accompanying reports, and the cannabis-related language is a mixed bag. The headline item for District residents is that the legislation would keep in place the long-running restriction that stops local officials in Washington, D.C. from setting up a legal, regulated marijuana sales market.
That rider has shaped the District's cannabis scene for years. Voters approved legalization of possession and home cultivation, but Congress has repeatedly used spending bills to prevent the city from creating a commercial retail system. The result is a gray market built around gifting and pop-up arrangements rather than licensed dispensaries, with the city's medical program operating separately. If the Senate version holds, that arrangement continues for another funding cycle.
The reports also address federal drug testing. They direct federal officials to keep testing safety-sensitive workers for cannabis even if marijuana is moved to a less restrictive schedule under rescheduling. In practical terms, that signals that a change in how the federal government classifies cannabis would not necessarily relax workplace rules for people in jobs tied to transportation and public safety. Workers in those fields, including many who live in the DMV area, would still face testing.
There is a more favorable note on the psychedelics side. The documents recognize the therapeutic potential of psychedelics, and they also comment on the effects of Schedule I status, a classification that critics say complicates research. Spending reports are not law, but they communicate congressional expectations to agencies and often foreshadow policy fights. With the House and Senate still to reconcile their approaches, the final outcome for D.C. sales, drug testing, and psychedelic research remains to be settled.







